Looking for Ozempic? Doctors are prescribing these diabetic alternatives for now | Connecticut Public
Novo Nordisk, Sanofi win FDA nods for diabetes drugs - Drug Delivery Business
Novo Nordisk wins first smart insulin pen approval for diabetes in China | BioWorld
Did Novo Illegally Use Diabetes Educators to Boost Drug Sales? | Insulin Nation
Novo Nordisk and the University of Toronto announce a combined C$40-million investment to address diabetes and chronic disease prevention
Novo Nordisk's type 2 diabetes drug gets health insurance coverage < Pharma < Article - KBR
Novo Nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article - KBR
Novo Nordisk's Ozempic is quick out of the blocks, chasing Lilly's Trulicity - PMLiVE
Novo Nordisk: Buy The Diabetes Treatment Leader On Recent Weakness (NYSE:NVO) | Seeking Alpha
Novo Nordisk wins FDA approval for higher-dose Ozempic for adults with type 2 diabetes - Drug Discovery and Development
Novo Nordisk targets type 2 diabetes mAbs in Xoma licensing deal
1.3 million Americans with diabetes rationed insulin in the past year, study finds - ABC17NEWS
Novo Nordisk - Wikipedia
Novo Nordisk Diabetes and Obesity Award; applications due May 1 | OHSU Research News
Novo Nordisk Insulin Pen Certification | novoMEDLINK™
Diabetes Disease Education for Patients | novoMEDLINK™
